Loading
A newer MRI dye given into a vein, approved in 2022 in the United States and 2023 in Europe, for brain and body scans including the liver, breast, lung and prostate in Europe.
Guerbet's Elucirem (NDA 216986, first approved 21 September 2022) and Bracco's Vueway carry the same American indication: MRI "to detect and visualize lesions with abnormal vascularity in: the central nervous system (brain, spine, and associated tissues) the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system)" in adults and children including term neonates. Both were authorised in the European Union on 7 December 2023 (EMEA/H/C/005626 and 006172) for pathologies of the central nervous system and of "the liver, kidney, pancreas, breast, lung, prostate, and musculoskeletal system". ATC V08CA12. Like every gadolinium-based contrast agent in the United States, its label carries a boxed warning on the risks of intrathecal use and nephrogenic systemic fibrosis, a thickening of skin and organs seen in people with severe kidney disease.
A gadolinium chelate that brightens tissue on MRI where it leaks from abnormal blood vessels.
| Region | Year | Indication |
|---|---|---|
| US | 2022 | MRI of lesions with abnormal vascularity in the central nervous system and the body · NDA 216986; Guerbet (Elucirem) and Bracco (Vueway) |
| EU | 2023 | Contrast-enhanced MRI of the central nervous system and the liver, kidney, pancreas, breast, lung, prostate and musculoskeletal system · Authorised 7 Dec 2023; Guerbet and Bracco Imaging |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Gadopiclenol" OR ABSTRACT:"Gadopiclenol" OR TITLE:"Elucirem" OR ABSTRACT:"Elucirem" OR TITLE:"gadopiclenol" OR ABSTRACT:"gadopiclenol" OR TITLE:"Vueway" OR ABSTRACT:"Vueway") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Gadopiclenol, not a curated reading list.
Shares Guerbet, Gadolinium-based and other MRI contrast agents, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Bracco (Bracco Imaging and Bracco Diagnostics), Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Guerbet, Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Bracco (Bracco Imaging and Bracco Diagnostics), Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI, Glioma & glioblastoma, Breast cancer (all types) and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI, Hepatocellular carcinoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/